Stock Information
CareDx Inc (CDNA)
Ticker Symbol: CDNA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $911.78 mil
Piotroski score: 7
PE Ratio: 16.6155
EPS (TTM): 0.8056
Revenue (TTM): $6.66 M
Dividend Yield: N/A%
ROE: 17.41%
Latest News
-
CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy - Slideshow
Thu, Feb 12, 2026 4:25 PM
-
CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript
Thu, Feb 12, 2026 4:24 PM
-
CareDx Announced Pivotal Clinical Validation Results Of AlloHeme, A Non-invasive, Next‑generation Sequencing-based, And AI-powered Monitoring Test Designed To Predict Relapse In Patients With Acute Myeloid Leukemia And Myelodysplastic Syndromes Following Allogeneic Hematopoietic Cell Transplant
Thu, Feb 12, 2026 8:13 AM
Key Financials
Financial data not available
